Article Sidebar
Published:
Oct 3, 2018Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Voltammetric determination of vildagliptin in a pharmaceutical formulation
Abstract
Purpose: To determine vildagliptin concentration in a pharmaceutical formulation using voltammetric analysis techniques, and optimize the parameters affecting the techniques.
Method: Four types of voltammetry techniques, including cyclic voltammetry (CV), differential pulse voltammetry (DPV), square wave voltammetry (SWV), and linear sweep voltammetry (LSV), were employed to measure vildagliptin. Platinum (Pt) and glassy carbon (GC) were used as working electrodes, while KNO3 (1 M) and phosphate buffer (NaH2PO4/H3PO4) pH 6.8 were used to study optimal voltammetric analysis conditions.
Results: CV results indicate that vildagliptin is electroactive and exhibits irreversible redox cycles while LSV results showed an oxidation peak current around 1.35 V that has high sensitivity and a linear standard regression line correlation coefficient of 0.9995. In addition, LSV results showed that vildagliptin has a lower limit of detection of ~ 0.241 mM and a limit of quantification of ~ 0.802 mM. Finally, the results show that vildagliptin has an acceptable level of recovery of 104.1 % and a relative standard deviation of 0.52 % for the commercially available vildagliptin tablets used in this study.
Conclusion: The accuracy and precision of all applied voltammetric techniques for vildagliptin analysis are within accepted limits stipulated in pharmaceutical analysis quality control guidelines. The recommended method for vildagliptin analysis is LSV with Pt as the working electrode and KNO3 (1 M) as the supporting electrolyte.
Keywords: Vildagliptin, Cyclic voltammetry, Square wave voltammetry, Differential pulse voltammetry, Linear sweep voltammetry
